Found 441 matching trials
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
PHASE1This study is a Phase 1b/2 multi-center study to assess the safety, tolerab...
Location
Seoul National University Bundang Hospital
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
PHASE2This is a single-center, open-label, phase I clinical trial aimed to evalua...
Location
Tianjin Medical University Cancer Institute and Hospital
ABT-510 in Treating Patients With Metastatic Melanoma
PHASE2RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Location
Multiple Locations
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
PHASE1This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Location
GSK Investigational Site
SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial
PHASE2The purpose of this study is to find out if SU011248 works and if it is saf...
Location
Tom Baker Cancer Centre
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
PHASE2This is a single-arm, phase II study aiming to evaluate the feasibility and...
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Micellar Paclitaxel to Treat Severe Psoriasis
PHASE2This study will evaluate the safety and effectiveness of micellar paclitaxe...
Location
National Cancer Institute (NCI)
Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents
N/AIn patients treated for exudative age-related macular degeneration (AMD), d...
Location
Centre Pôle Vision du val d'Ouest
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
NAAnti-angiogenesis Tyrosine kinase inhibitors (TKIs) have been proved to sho...
Location
Musculoskeletal Tumor Center of Peking University People's Hospital
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
PHASE2Providing more theoretical basis for the prediction of the efficacy of adva...
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University